Profil Financier
Du Jinhao occupe actuellement le rang #1515 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.8 B (+$146 sur 24h).
Du Jinhao chairs Shanghai Allist Pharmaceuticals, a drug supplier based in Shanghai.
Co-founded by Du in 2004, Shanghai Allist specializes in tumor treatment and employs 130 scientists and researchers.
Du, who took the company public in Shanghai in 2020, is a tenured scientist at the National Institutes of Health (NIH) in the U.S.